Updated:
Thornapple River Capital
Thornapple River Capital is a closely held investment partnership that invests in and supports teams across healthcare, biotech, medical devices, AIML,...
Thornapple River Capital
Thornapple River Capital is a closely held investment partnership that invests in and supports teams across healthcare, biotech, medical devices, AIML, deeptech, alt. transport, and more. It builds and invests in early-stage companies.
General information
Firm type
Generalist
Year founded
2015
Location
Region
North America
Country
United States
City
Grand Rapids
Corporate office
Grand Rapids, MI, United States
Frequently asked questions
What investment stages does the firm typically target?
Thornapple River Capital's stated mandate spans early-stage seed rounds, start-up financing, and growth equity. The firm advertises no stage minimums, no check-size disclosures, and no follow-on reserve policy. Without a portfolio list, the actual stage concentration cannot be independently verified.
Does the firm participate in fund commitments or only direct deals?
Thornapple River Capital has not disclosed whether it invests directly into companies, through SPVs, or as a limited partner in third-party venture funds. Its public materials reference only a direct investment posture across stages, but the absence of portfolio detail leaves the execution model unclear.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: